Evidence map›Paper›PMID 31338700›Full record

ArticleClinical rheumatology2019

Antineutrophil cytoplasmic antibodies and their relationship with disease activity and presence of staphylococcal superantigens in nasal swabs in patients having granulomatosis with polyangiitis: results of a study involving 115 patients from a single center.

Justyna Fijolek, E Wiatr, V Petroniec, E Augustynowicz-Kopec, M Bednarek, D Gawryluk, K Roszkowski-Sliz

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Justyna FijolekThe Third Department of Pneumonology, National Tuberculosis and Lung Diseases Research Institute, Plocka St 26, 01-138, Warsaw, Poland. jfijolek@op.pl.ORCID http://orcid.org/0000-0002-9135-1580
E WiatrThe Third Department of Pneumonology, National Tuberculosis and Lung Diseases Research Institute, Plocka St 26, 01-138, Warsaw, Poland.
V PetroniecDepartment of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
E Augustynowicz-KopecDepartment of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
M BednarekThe Second Department of Pneumonology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
D GawrylukThe Third Department of Pneumonology, National Tuberculosis and Lung Diseases Research Institute, Plocka St 26, 01-138, Warsaw, Poland.
K Roszkowski-SlizThe Third Department of Pneumonology, National Tuberculosis and Lung Diseases Research Institute, Plocka St 26, 01-138, Warsaw, Poland.
Masih Daneshvari Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAntineutrophil cytoplasmic antibodies (ANCAs) are considered a risk factor for granulomatosis with polyangiitis (GPA) exacerbation, especially when staphylococcal superantigens (SAgs) are present in nasal swabs. Their role in monitoring disease activity remains controversial. This study determined the relationship of ANCAs with disease activity and presence of SAgs in GPA patients.

methodsAmong a total of 115 GPA patients hospitalized in the period 2009-2016, we investigated the presence of SAgs and ANCA concentration. Blood samples and nasal swabs were taken at each visit (referred further to as episodes). Disease activity was assessed using the Birmingham Vasculitis Activity Score (BVAS).

resultsWe analyzed 362 episodes. ANCAs were detected in 215 (59.4%), while SAgs were detected in 126 (34.8%) episodes. We found a significant correlation between the presence of ANCAs and disease activity (p = 0.0032), as well as between their level and GPA severity (r = 0.25363, p = 0.000001). We also determined that an ANCA values ≥ 138 Ru/ml were an indicator of active disease with high specificity and low sensitivity (84.4% and 37.3%, respectively). The relationship between ANCA presence and the presence of SAgs was not confirmed; however, when SAgs were analyzed based on the different types, ANCA levels were found to be significantly higher in the group with SAg type B (p = 0.031).

conclusionsThere was no detectable evidence for the association between ANCA level and the presence of SAgs. Although monitoring ANCA levels as a marker of disease activity may be clinically relevant, GPA management cannot proceed on the basis of ANCA levels alone. Key Points • ANCA concentration usually correlates with GPA activity, although in half of patients, ANCAs persist despite effective treatment and clinical remission. • ANCA values of 138 Ru/ml seem to be an indicator of active disease with high specificity, but low sensitivity. • Although there is a relevance for ANCA monitoring as a marker of disease activity, GPA management cannot be based on ANCA levels alone. • The suspected clinical correlation between ANCA formation and SAg presence in nasal swabs is not obvious and requires further investigations.

Indexed as

AdultAntibodies, Antineutrophil CytoplasmicFemaleGranulomatosis with PolyangiitisHumansMaleMiddle AgedRetrospective StudiesStaphylococcusSuperantigensAntibodies, Antineutrophil CytoplasmicSuperantigensAntineutrophil cytoplasmic antibodiesDisease activityGranulomatosis with polyangiitisStaphylococcal superantigens

Identifiers

PMID31338700
OpenAlexW2963501760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.